Cellectar Biosciences, Inc. - Common Shares (CLRB)
CUSIP: 15117F500
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 4,503,909
- Total 13F shares
- 262,671
- Share change
- +59,624
- Total reported value
- $407,000
- Price per share
- $1.55
- Number of holders
- 9
- Value change
- +$89,332
- Number of buys
- 4
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 15117F500?
CUSIP 15117F500 identifies CLRB - Cellectar Biosciences, Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 15117F500:
Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
13F
|
Company |
7.5%
|
337,565
|
$750,000 | — | 30 Sep 2018 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.9%
|
87,500
|
$263,000 | — | 30 Sep 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
58,553
|
$176,000 | — | 30 Sep 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.49%
|
22,221
|
$67,000 | — | 30 Sep 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.37%
|
16,755
|
$50,000 | — | 30 Sep 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.23%
|
10,300
|
$31,000 | — | 30 Sep 2018 | |
| AWM Investment Company, Inc. |
13F
|
Company |
—
class O/S missing
|
106,600
|
$9,000 | — | 30 Sep 2018 | |
| US BANCORP \DE\ |
13F
|
Company |
0.06%
|
2,857
|
$9,000 | — | 30 Sep 2018 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
2,541
|
$8,000 | — | 30 Sep 2018 | |
| Vigilant Capital Management, LLC |
13F
|
Company |
0.04%
|
2,000
|
$6,000 | — | 30 Sep 2018 | |
| Iron Gate Global Advisors LLC |
13F
|
Company |
0.02%
|
953
|
$2,000 | — | 30 Sep 2018 | |
| Sonora Investment Management, LLC |
13F
|
Company |
—
class O/S missing
|
500
|
$2,000 | — | 30 Sep 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
320
|
$1,000 | — | 30 Sep 2018 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q4 2018
As of 31 Dec 2018,
Cellectar Biosciences, Inc. - Common Shares (CLRB) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
262,671 shares.
The largest 9 holders included
SPHERA FUNDS MANAGEMENT LTD., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, UBS Group AG, US BANCORP \DE\, and LADENBURG THALMANN FINANCIAL SERVICES INC..
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
9
Q4 2018 holders
9
Holder diff
0
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.